Therapeutic Exploratory Study of CWP-0403

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

April 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CWP-0403 100mg

100mg/tablet, Twice a day, 1 tablet at a time for 12 weeks

DRUG

placebo

"Tablet not containing CWP-0403 and indistinguishable from CWP-0403 50mg, 100mg tablets.~Twice a day, 1 tablet at a time for 12 weeks"

DRUG

CWP-0403 50mg

50mg/tablet, Twice a day, 1 tablet at a time for 12 weeks

Trial Locations (10)

Unknown

Chonbuk National University Hospital, Seoul

Ewha Womans University Mokdong Hospital, Seoul

Gachon Medical School Gil Medical Center, Seoul

Inha University Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyungpook National University Hospital, Seoul

Seoul National University Bundang Hopital, Seoul

The Catholic University of Korea, Holly Family Hospital, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

The Catholic University of Korea, St. Vincent's Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY

NCT00888719 - Therapeutic Exploratory Study of CWP-0403 | Biotech Hunter | Biotech Hunter